Access the full text.
Sign up today, get DeepDyve free for 14 days.
Dao-feng Yang, Wen-hong Qiu, Hui-fen Zhu, P. Lei, Xue Wen, H. Dai, W. Zhou, G. Shen (2008)
CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.Transplant immunology, 19 3-4
(2010)
pCTLA-Ig gene-modified porcine immature dendritic cells inhibit the proliferation of xenogenetic spleen cells
M. Koulmanda, T. Laufer, H. Auchincloss, R. Smith (2004)
Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect responseXenotransplantation, 11
Clarkson (2005)
T-cell costimulatory pathways in allograft rejection and toleranceTransplantation, 80
R. Pierson, A. Dorling, D. Ayares, M. Rees, J. Seebach, J. Fishman, B. Hering, D. Cooper (2009)
Current status of xenotransplantation and prospects for clinical applicationXenotransplantation, 16
Andrew Vaughan, P. Malde, N. Rogers, Ian Jackson, R. Lechler, A. Dorling (2000)
Porcine CTLA4-Ig Lacks a MYPPPY Motif, Binds Inefficiently to Human B7 and Specifically Suppresses Human CD4+ T Cell Responses Costimulated by Pig But Not Human B71The Journal of Immunology, 165
A. Dorling, G. Lombardi, R. Binns, R. Lechler (1996)
Detection of primary direct and indirect human anti‐porcine T cell responses using a porcine dendritic cell populationEuropean Journal of Immunology, 26
K. Smith, P. Garside, R. Mcneil, J. Brewer (2006)
Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses.Vaccine, 24 15
T. Min, L. Yi, Z. Chao, Z. Haitao, W. Wei, Y. Liang, W. Bo (2010)
Superiority of visipaque (iodixanol)-controlled density gradient over Ficoll-400 in adult porcine islet purification.Transplantation proceedings, 42 5
L. Graça (2008)
CTLA4Ig and the therapeutic potential of T cell co-stimulation blockade.Acta reumatologica portuguesa, 33 3
M. Uslenghi, Isabella Pagano, C. Pontoni, Salvatore Scuderi, Boris INAFIASF-Milano, INAFCatania Observatory, Inasan, Moscow (2008)
The World Space Observatory (WSO-UV) - Current statusarXiv: Astrophysics
Lei Guo, M. Fujino, H. Kimura, N. Funeshima, Y. Kitazawa, Y. Harihara, K. Tezuka, M. Makuuchi, Seiichi Suzuki, Xiao‐Kang Li (2003)
Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.Transplant immunology, 12 1
M. Kvist, M. Kanje, H. Ekberg, M. Corbascio, L. Dahlin (2008)
Costimulation blockade in transplantation of nerve allografts: long‐term effectsJournal of the Peripheral Nervous System, 13
V. Mirenda, D. Golshayan, J. Read, I. Berton, A. Warrens, A. Dorling, R. Lechler (2005)
Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses.Diabetes, 54 4
N. Tonomura, A. Shimizu, Shumei Wang, Kazuhiko Yamada, V. Tchipashvili, G. Weir, Yong-Guang Yang (2008)
Pig islet xenograft rejection in a mouse model with an established human immune systemXenotransplantation, 15
K. Jen, V. Jain, S. Makani, P. Finn (2006)
Immunomodulation of allergic responses by targeting costimulatory moleculesCurrent Opinion in Allergy and Clinical Immunology, 6
JoAnne Greene, G. Leytze, J. Emswiler, R. Peach, J. Bajorath, W. Cosand, P. Linsley (1996)
Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions*The Journal of Biological Chemistry, 271
Vijay Garapati, M. Lefranc (2007)
IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors.Developmental and comparative immunology, 31 10
D. Rothstein, M. Sayegh (2003)
T‐cell costimulatory pathways in allograft rejection and toleranceImmunological Reviews, 196
B. Salomon, J. Bluestone (2001)
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.Annual review of immunology, 19
Ying Ma, Birong Lin, B. Lin, S. Hou, Wei-zhu Qian, Jing Li, Min Tan, Jianmei Ma, Bo-hua Li, Hao Wang, A. Wen, Ya-jun Guo (2009)
Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis, 30
J. Slavik, J. Hutchcroft, B. Bierer (1999)
CD28/CTLA-4 and CD80/CD86 familiesImmunologic Research, 19
K. Cardona, G. Korbutt, Z. Milas, J. Lyon, J. Cano, Wan-lin Jiang, Hameeda Bello-Laborn, Brad Hacquoil, E. Strobert, Shivaprakash Gangappa, C. Weber, T. Pearson, R. Rajotte, C. Larsen (2006)
Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathwaysNature Medicine, 12
B. Hering, M. Wijkstrom, M. Graham, M. Hårdstedt, T. Aasheim, T. Jie, J. Ansite, M. Nakano, Jane Cheng, Wei Li, K. Moran, U. Christians, Colleen Finnegan, C. Mills, D. Sutherland, P. Bansal‐Pakala, M. Murtaugh, N. Kirchhof, H. Schuurman (2006)
Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primatesNature Medicine, 12
Zhai C, Yu L, Zhu H, Tian M, Xiaogang Z, Bo W. Porcine CTLA4‐Ig prolong islet xenografts in rats by downregulating the direct pathway of T‐cell activation. Xenotransplantation 2011; 18: 40–45. © 2011 John Wiley & Sons A/S. Abstract: Aim: Porcine pancreatic islets fused with pCTLA4‐Ig were transplanted into diabetic rats. Xenografts survival was observed, and the underlying immunological rejection mechanisms were investigated. Methods: Control porcine islets, empty vector (Adv‐GFP)–transfected, and gene‐modified porcine islets were transplanted into the renal capsule of diabetic rats. The survival rates of the xenografts were observed. Changes in serum levels of IL‐4 and γ‐IFN in the recipients were assessed. Results: The survival time of xenografts in the gene‐modified porcine islets group was 34.50 ± 4.14 days, which was longer than those in the control group (34.50 ± 4.14 days vs. 7.43 ± 1.72 days and 7.22 ± 1.72 days; P < 0.01). Changes in the serum levels of IL‐4 and γ‐IFN between the groups of rats post‐transplantation indicated the differentiation bias of T helper cells. Conclusions: The donor‐originated pCTLA‐IgG4 fusion protein inhibits the direct pathway of recipient T‐cell priming, which might prolong xenograft survival.
Xenotransplantation – Wiley
Published: Jan 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.